Activated natural killer (NK) cells mediate graft-versus-tumor (GVT) effects but inhibit graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation.

被引：0
|
作者：
Murphy, WJ
Tian, Z
Asai, O
Hornung, R
Longo, DL
机构：
[1] NCI,FREDERICK CANC RES & DEV CTR,DES,LAB LEUKOCYTE BIOL,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES & DEV CTR,SAIC,BCDP,FREDERICK,MD 21701
[3] NIA,BALTIMORE,MD 21224
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [41] Incidence and risks for sclerodermatous chronic graft-versus-host disease after allogeneic marrow or blood transplantation.
    Pavletic, SZ
    Lynch, JC
    Sannoufi, S
    Ketcham, MA
    Bishop, MR
    Tarantolo, S
    Bociek, RG
    Kessinger, MA
    BLOOD, 2000, 96 (11) : 194A - 195A
  • [42] Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine
    Anderson, LD
    Petropoulos, D
    Everse, LA
    Mullen, CA
    CANCER RESEARCH, 1999, 59 (07) : 1525 - 1530
  • [43] Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
    Higo, Seiichiro
    Shimizu, Akira
    Masuda, Yukinari
    Nagasaka, Shinya
    Kajimoto, Yusuke
    Kanzaki, Go
    Fukui, Megumi
    Nagahama, Kiyotaka
    Mii, Akiko
    Kaneko, Tomohiro
    Tsuruoka, Shuichi
    PLOS ONE, 2014, 9 (12):
  • [44] BONE-MARROW TRANSPLANTATION AND GRAFT-VERSUS-HOST DISEASE
    POWLES, RL
    CURRENT OPINION IN IMMUNOLOGY, 1990, 2 (06) : 870 - 875
  • [45] Elimination of leukemia in the absence of lethal graft versus host disease after allogeneic bone marrow transplantation.
    Drobyski, WR
    Gendelman, M
    Vodanovic-Jankovic, S
    Gorski, J
    BLOOD, 2002, 100 (11) : 819A - 819A
  • [46] CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
    Edinger, M
    Hoffmann, P
    Ermann, J
    Drago, K
    Fathman, CG
    Strober, S
    Negrin, RS
    NATURE MEDICINE, 2003, 9 (09) : 1144 - 1150
  • [47] Eosinophilia as a presenting sign for chronic graft versus host disease after allogeneic bone marrow transplantation.
    Hsu, Y
    Cohen, A
    Couriel, DR
    BLOOD, 2003, 102 (11) : 462B - 462B
  • [48] Vaccine induced graft-versus-tumor effects are separable from graft-versus-host disease.
    Teshima, T
    Mach, N
    Hill, GR
    Dranoff, G
    Ferrara, JLM
    BLOOD, 1999, 94 (10) : 635A - 635A
  • [49] CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
    Matthias Edinger
    Petra Hoffmann
    Joerg Ermann
    Kathryn Drago
    C Garrison Fathman
    Samuel Strober
    Robert S Negrin
    Nature Medicine, 2003, 9 : 1144 - 1150
  • [50] Eosinophilic cationic protein (ECP) as a marker of graft versus host disease (GVHD) in pediatric allogeneic bone marrow transplantation.
    Cole, CH
    Loh, R
    BLOOD, 1997, 90 (10) : 4398 - 4398
12345